FLS
73
4
CFG
48
-2
BA
65
2
C
60
-2
EOG
36
2
AVB
57
2
DLTR
51
-3
CHD
34
-5
GME
57
5
AMGN
33
-3
WEC
43
-2
ROST
66
-2
MTB
42
-4
SLG
53
-2
IR
58
-2
JNJ
35
-6
MCD
57
-5
GD
39
-2
AVGO
47
12
VFC
56
3
FLS
73
4
CFG
48
-2
BA
65
2
C
60
-2
EOG
36
2
AVB
57
2
DLTR
51
-3
CHD
34
-5
GME
57
5
AMGN
33
-3
WEC
43
-2
ROST
66
-2
MTB
42
-4
SLG
53
-2
IR
58
-2
JNJ
35
-6
MCD
57
-5
GD
39
-2
AVGO
47
12
VFC
56
3
Financhill
Back

Covalon Technologies 10K Form

Sell
42

COV.V
Covalon Technologies

Last Price:
3.40
Seasonality Move:
7.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COV.V News And Ratings

See the #1 stock for the next 7 days that we like better than COV.V

COV.V Financial Statistics

Sales & Book Value

Annual Sales: $26.6M
Cash Flow: $2.12M
Price / Cash Flow: 0
Annual Sales: $0.88
Price / Book: 3.96

Profitability

EPS (TTM): -0.03000
Net Income (TTM): $-823.4K
Gross Margin: $14.36M
Return on Equity: -4.02%
Return on Assets: -3.34%

Covalon Technologies Earnings Forecast

Key Covalon Technologies Financial Ratios

  • The Gross Profit Margin over the past 18 years for COV.V is 54.00%.
  • The Selling, General & Administrative Expenses for COV.V have been equal to 58.55% of Gross Profit Margin.
  • The Research & Development expenses have been 5.31% of Revenue.
  • The Interest Expense is -1.15% of Operating Income.
  • The Net Earning history of COV.V is -16.77% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Covalon Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSXV
Industry: Biotechnology
Sector: Health Care
Current Symbol: COV.V
Website: covalon.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.24
Quick Ratio: 3.55

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 49.71

COV.V Technical Analysis vs Fundamental Analysis

Sell
42
Covalon Technologies (COV.V) is a Sell

Is Covalon Technologies a Buy or a Sell?